Attana AB (publ) (NGM:ATANA)

Market Cap	34.56M
Revenue (ttm)	5.69M
Net Income (ttm)	-11.72M
Shares Out	1.92B
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,465,556
Average Volume	20,491,895
Open	n/a
Previous Close	0.0200
Day's Range	n/a
52-Week Range	0.0050 - 0.0820
Beta	0.73
RSI	40.83
Earnings Date	Oct 28, 2025

About Attana AB

Attana AB (publ) provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia. The company offers analytical biosensor which allows studies on molecular interactions between proteins, DNA, and carbohydrates, as well as interactions to cells cultured; contract research services; and attana virus analytics. It serves academic institutions, biotech companies, and pharma companies. The company has a collaboration with the Linnaeus University. Attana AB (publ) was founded in 2002 and is headq...

• Industry: Commercial Physical and Biological Research
• Founded: 2002
• Employees: 6
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: ATANA

Financial Performance

In 2024, Attana AB's revenue was 6.61 million, a decrease of -3.02% compared to the previous year's 6.82 million. Losses were -12.78 million, -7.33% less than in 2023.